RDY

Dr Reddys Labs

13.07

+0.17+1.32%

After Hours: 13.07 0.00 0.00%19:30 10/16 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE13.05/13.07

TODAY RANGE13.02-13.12

VOL1.50M

MARKET CAP10.90B

52 WEEK RANGE11.28-15.56

AVG VOL (3M)2.91M

% TURNOVER0.18%

TURNOVER--

P/E (TTM)31.06

% RANGE0.77%

EPS(TTM)0.4211

P/E(FORWARD)26.84

P/B2.681

BVPS4.879

DIVIDEND0.0834

P/S3.030

BETA--

DIV YIELD0.64%

FREE FLOAT MKT CAP10.89B

SHARES OUTSTANDING832.99M

NEXT EARNINGS10/22-10/26

FREE FLOAT832.74M

LOT SIZE1

EX-DATE07/24/2026

News

Press Releases

Financial Reports

Profile

TipRanks·5d ago
Dr. Reddy’s Receives USFDA Form 483 After Pre-Approval Inspection at Visakhapatnam Plant
NASDAQ·10/12 19:24
Top Stock Reports for Oracle, American Express & Progressive
TipRanks·10/12 10:10
Dr. Reddy’s upgraded to Outperform from Neutral at BNP Paribas
TipRanks·10/08 13:57
Dr. Reddy’s Receives Two-Observation USFDA Form 483 After PAI at FTO-11
TipRanks·10/07 11:17
Dr. Reddy’s Sets October 23 Date for Q2 FY27 Results and Global Earnings Call
TipRanks·10/05 10:27
Dr. Reddy’s U.S. Subsidiary Hit with Modest IRS Penalty, Assessed as Non‑Material
TipRanks·10/01 15:10
Analysts Offer Insights on Healthcare Companies: Zentek (OtherZTEKF) and Dr Reddy’s Laboratories (RDY)
Dow Jones·09/29 17:58
Dr Reddy's Labs Price Target Raised to $1450.00/Share From $1040.00 by Citigroup
Dow Jones·09/29 17:58
Dr Reddy's Labs Raised to Buy From Sell by Citigroup
Dow Jones·09/29 04:02
Dr. Reddy's North America Revenue Expected to Trough -- Market Talk
TipRanks·09/29 01:35
Dr. Reddy’s double-upgraded to Buy from Sell at Citi
TipRanks·09/22 18:51
Dr. Reddy’s Schedules October 23 Board Meet, Closes Trading Window Ahead of Q2 Results
TipRanks·09/21 17:57
Dr. Reddy’s Schedules Nomura-Led Investor Meet in Hyderabad
TipRanks·09/18 10:48
Dr. Reddy’s, Takeda Seal Exclusive Deal to Launch First Approved Dengue Vaccine in India’s Private Market
TipRanks·09/14 10:58
Dr. Reddy’s Reports FDA Records Assessment at Mexican API Plant Concluding with Two Observations

Same Industry

Name/Symbol

Change%

Price

Dr Reddys Labs

RDY

+1.32%

13.07

MCK

BIIB

Amgen Inc

AMGN

-0.35%

432.49

SHPG

CELG-RT

Celgene

CELG

0.00%

108.24

LLY

TXMD

Johnson & Johnson

JNJ

+0.90%

255.56

Abbvie Inc

ABBV

+0.71%

285.42

ZTS

GILD

NVO

BMY

ALXN

Pfizer

PFE

+0.48%

29.58

SNY

GCVRZ

Novartis

NVS

+0.16%

150.62

GSK PLC

GSK

+1.00%

49.51

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.